Largest Biotech ETFs by marketcap

ETFs: 30 total market cap: โ‚น3.259 T suggest/edit icon suggest/edit icon download icondownload icon
RankName
Market CapPriceTodayPrice (30 days)FeeMarket
favorite icon1
โ‚น1.024 Tโ‚น19,8360.60%0.44%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon2
โ‚น962.87 Bโ‚น13,9751.16%0.35%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon3
โ‚น287.17 Bโ‚น25,3020.59%0.55%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon4
โ‚น167.57 Bโ‚น3,8963.96%0.75%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon5
โ‚น163.41 Bโ‚น10,4420.14%0.37%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon6
โ‚น128.20 Bโ‚น1,0000.02%0.35%๐Ÿ‡ช๐Ÿ‡บ EU
favorite icon7
โ‚น103.99 Bโ‚น11,5710.45%0.36%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon8
โ‚น62.34 Bโ‚น7,1540.06%0.40%๐Ÿ‡ช๐Ÿ‡บ EU
favorite icon9
โ‚น57.60 Bโ‚น12,3350.24%0.56%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon10
โ‚น50.01 Bโ‚น23,6310.79%0.35%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon11
โ‚น48.17 Bโ‚น19,4693.50%0.97%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon12
โ‚น40.45 Bโ‚น9,1110.88%0.58%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon13
โ‚น31.51 Bโ‚น3,7290.97%0.47%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon14
โ‚น19.83 Bโ‚น3,8430.43%0.99%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon15
โ‚น17.29 Bโ‚น5,1611.21%0.50%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon16
โ‚น12.49 Bโ‚น1,0272.08%0.50%๐Ÿ‡ช๐Ÿ‡บ EU
favorite icon17
โ‚น12.11 Bโ‚น3,3300.55%0.19%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon18
โ‚น10.57 Bโ‚น41.152.11%1.14%๐Ÿ‡ญ๐Ÿ‡ฐ HK
favorite icon19
โ‚น10.53 Bโ‚น5,6472.49%0.50%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon20
โ‚น10.16 Bโ‚น736.463.90%0.75%๐Ÿ‡ช๐Ÿ‡บ EU
favorite icon21
โ‚น9.46 Bโ‚น10,7521.80%0.95%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon22
โ‚น7.83 Bโ‚น721.243.50%0.97%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon23
โ‚น5.46 Bโ‚น3,6900.67%0.99%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon24
โ‚น4.93 Bโ‚น2,4030.74%0.45%๐Ÿ‡ช๐Ÿ‡บ EU
favorite icon25
โ‚น3.71 Bโ‚น1,7234.58%1.28%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon26
โ‚น2.33 Bโ‚น1,4610.93%0.49%๐Ÿ‡ช๐Ÿ‡บ EU
favorite icon27
โ‚น2.32 Bโ‚น2,5530.64%0.35%๐Ÿ‡ช๐Ÿ‡บ EU
favorite icon28
โ‚น1.51 Bโ‚น4,1140.90%0.30%๐Ÿ‡ช๐Ÿ‡บ EU
favorite icon29
โ‚น0.43 Bโ‚น2,0861.45%0.45%๐Ÿ‡บ๐Ÿ‡ธ US
favorite icon30
โ‚น0.16 Bโ‚น1,0070.00%0.95%๐Ÿ‡บ๐Ÿ‡ธ US

This list includes exchange-traded funds that invest in biotechnology companies, providing exposure to firms focused on medical research, drug development, and innovative healthcare solutions.